Back
Charter Communications Vs. Celldex Therapeutics Industry Stock Comparison
Sell
28
CHTR
Charter Communications
Last Price:
317.06
Seasonality Move:
0.78%
Sell
37
CLDX
Celldex Therapeutics
Last Price:
32.87
Seasonality Move:
1.08%
Sell
28
Charter Communications (CHTR)
is a Sell
Is Charter Communications a Buy, Sell or Hold?
- The current Charter Communications [CHTR] share price is $314.49. The Score for CHTR is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- CHTR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Celldex Therapeutics (CLDX)
is a Sell
Is Celldex Therapeutics a Buy, Sell or Hold?
- The current Celldex Therapeutics [CLDX] share price is $36.02. The Score for CLDX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- CLDX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CHTR Stock Price Chart
What is Charter Communications's stock price today?
-
The Charter Communications share price today is $314.49
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CHTR is experiencing selling pressure, which indicates risk of future bearish movement.
CLDX Stock Price Chart
What is Celldex Therapeutics's stock price today?
-
The Celldex Therapeutics share price today is $36.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLDX is experiencing slight selling pressure.
CHTR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.93 | Sell |
Relative Strength Index (14 RSI): | 33.32 | Sell |
Chaikin Money Flow: | -1675907 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (326.5 - 349.52) | Sell |
Bollinger Bands (100): | (279.53 - 348.39) | Buy |
CLDX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.42 | Buy |
Relative Strength Index (14 RSI): | 37.46 | Sell |
Chaikin Money Flow: | -2311480 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.03 - 43.15) | Sell |
Bollinger Bands (100): | (34.54 - 41.04) | Sell |
CHTR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 331.71 | Sell |
20-day SMA: | 334.98 | Sell |
50-day SMA: | 344.19 | Sell |
200-day SMA: | 315.46 | Sell |
8-day EMA: | 328.03 | Sell |
20-day EMA: | 334.28 | Sell |
50-day EMA: | 333.5 | Sell |
200-day EMA: | 328.52 | Sell |
CLDX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.69 | Sell |
20-day SMA: | 41.52 | Sell |
50-day SMA: | 38.47 | Sell |
200-day SMA: | 38.87 | Sell |
8-day EMA: | 40.13 | Sell |
20-day EMA: | 40.37 | Sell |
50-day EMA: | 39.15 | Sell |
200-day EMA: | 37.62 | Sell |
Charter Communications Earnings Growth & CHTR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.60 per share, a decrease next quarter of $0.27 per share, an increase this year of $1.94 per share, and an increase next year of $1.07 per share.
Celldex Therapeutics Earnings Growth & CLDX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.18 per share, an increase this year of $0.19 per share, and a decrease next year of $0.66 per share.
Charter Communications Technical Analysis
Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Celldex Therapeutics Technical Analysis
Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |